Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. II. Antilipolytic and hypoglycemic effects in vivo.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002247:Carbon Isotopes; D003920:Diabetes Mellitus / Q000139:chemically induced; D003964:Diaphragm / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D005989:Glycerides / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats
D001786:Blood Glucose; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D005989:Glycerides; D009539:Nicotinic Acids; D011720:Pyrazoles; D006003:Glycogen; D005947:Glucose